Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
06/2007
06/14/2007US20070134672 Charcot-Marie-Tooth disease Type 1A (CMT1A) and Hereditary Neuropathy with liability to Pressure Palsies (HNPP); accuracy of detecting duplication and deletion in the chromosome 17p11.2-p12 region is greater than 99.9%
06/14/2007US20070134671 Oligonucleotides for detection of leishmaniasis and methods thereof
06/14/2007US20070134670 Methods for prediction and prognosis of cancer, and monitoring cancer therapy
06/14/2007US20070134669 Method for diagnosis/prognosis of breast cancer
06/14/2007US20070134668 Method for analysis by molecular hybridization of nucleic acids and kit for carrying out said method
06/14/2007US20070134667 Molecular single electron transistor (mset) detector device
06/14/2007US20070134666 Simultneous analytical method for oxidatively damaged guanine compound and concentration correcting substance thereof, and analyzer used for this analytical method
06/14/2007US20070134665 Method of in situ detection of proteins using aptamers
06/14/2007US20070134664 Human autism susceptibility gene and uses thereof
06/14/2007US20070134663 Interaction inhibitors, method of detecting interaction inhibitor and kit detecting interaction inhibitor
06/14/2007US20070134662 Structural interaction fingerprint
06/14/2007US20070134661 method for genotyping using inter alia, a chip comprising a support for nucleic acid hybridization having immobilized thereon an oligonucleotide probe complementary to the target nucleotide sequence and an oligonucleotide control probes
06/14/2007US20070134660 Methods for identifying modulators of kinesin activity
06/14/2007US20070134659 Polynucleotides for the detection of salmonella species
06/14/2007US20070134658 Identification of fetal dna and fetal cell markers in maternal plasma or serum
06/14/2007US20070134657 Methods and compositions relating to gradient exposed cells
06/14/2007US20070134656 Product and method
06/14/2007US20070134655 a nucleotide sequence of a first half of said RNA precursor is a partial inversed-reversed sequence of a nucleotide sequence of a second half
06/14/2007US20070134654 Means for use in treating diseases correlated with or caused by non-physiological levels of microtubule-associated pp2ac
06/14/2007US20070134653 drug screening using virion infectivity factor (VIF) activity as diagnostic tool in screening viricidal activity of compounds; for treating viral diseases
06/14/2007US20070134652 Multiplexed quantitative detection of pathogens
06/14/2007US20070134651 Apparatus and method for measuring activity signals of biological samples
06/14/2007US20070134650 Scleraxis
06/14/2007US20070134649 Method for monitoring the presence of biofilmforming microorganisms in paper industry
06/14/2007US20070134648 Affinity-based enrichment of phosphorylated peptides and/or proteins
06/14/2007US20070134337 Bacteria binding products
06/14/2007US20070134270 Chicken rna polymerase i promoter and the use thereof
06/14/2007US20070134262 Polypeptide encoded by an alternative reading frame of a pathogenic virus or a fragment comprising more than 7 amino acids; Hepatitis A virus, Hepatitis B virus, Hepatitis C virus, Hepatitis D virus, Hepatitis E virus, Hepatitis F virus Hepatitis G virus, Human Immunodeficiency virus, Influenza virus
06/14/2007US20070134261 Effectors of innate immunity
06/14/2007US20070134256 Chimpanzee Fab antibodies against DENV-4; isolated nucleic acids encoding the antibodies of the invention and host cells transformed therewith
06/14/2007US20070134253 Serpentine transmembrane epithelial antigens of the prostate; polynucleotides, recombinant expression vectors, and host cells; anticarcinogenic agents; diagnosis and prognosis of urogenital and bone cancers and lymphomas
06/14/2007US20070134252 Using tumor biomarkers to prognose cancer progression and designing antitumor agent which decrease signal from growth factor receptors
06/14/2007US20070134251 Detection of expression of biomarkers is predictive or indicative that the tissue or cell sample will be sensitive to apoptosis-inducing agents such as Apo2L/TRAIL and anti-DR5 agonist antibodies; fucosyltransferase 3 (FUT3) and/or fucosyltransferase 6 (FUT6);
06/14/2007US20070134250 Composition Comprising and Method of Using Angiopoietin-Like Protein 3 ANGPTL3
06/14/2007US20070134249 Combination therapy and antibody panels
06/14/2007US20070134238 Modulation of T Cell Differentiation for the Treatment of T Helper Cell Mediated Diseases
06/14/2007US20070134237 Human cytokine receptor
06/14/2007US20070134226 Heparan sulfate glycosaminoglycan lyase and uses thereof
06/14/2007US20070134134 Method and apparatus for obtaining aliquot from liquid-based cytological sample
06/14/2007US20070132535 Electromagnetic device, high-voltage generating device, and method for making the electromagnetic device
06/14/2007US20070131565 Method of measuring blood component, sensor used in the method, and measuring device
06/14/2007US20070131549 Glucose biosensor and method
06/14/2007DE102005059536A1 Verfahren und Biochip zur Untersuchung einer biologischen Probe Methods and biochip for assaying a biological sample
06/14/2007DE102005059535A1 Vorrichtung und Verfahren zur Durchführung eines Nukleinsäure-Tests, sowie Verfahren zur Herstellung einer solchen Vorrichtung Apparatus and method for performing a nucleic acid assay, and processes for producing such a device
06/14/2007DE102005059242A1 Molekulare Marker für eine Tumordiagnose und -therapie Molecular markers for tumor diagnosis and therapy
06/14/2007DE102005059227A1 Verfahren zur Bestimmung des Genotyps aus einer biologischen Probe enthaltend Nukleinsäuren unterschiedlicher Individuen A method for determining the genotype of a biological sample containing nucleic acids of different individuals
06/14/2007DE102005058431A1 Nucleic acid useful as a target for detecting species of yeasts and/or filamentous fungi comprises an elongation factor 3 gene or a fragment thereof
06/14/2007DE102004053918B4 Aptamerbasiertes Testsystem Aptamerbasiertes test system
06/14/2007CA2633815A1 Module-level analysis of peripheral blood leukocyte transcriptional profiles
06/14/2007CA2632586A1 Method for the diagnosis and treatment of cardiovascular diseases
06/14/2007CA2632456A1 An hiv-1 latency model for high throughput screening
06/14/2007CA2631881A1 Methods, plasmid vectors and primers for assessing hiv viral fitness
06/14/2007CA2631706A1 Methods of identifying agents that modulate mitochondrial function
06/14/2007CA2630597A1 Effects of inhibitors of fgfr3 on gene transcription
06/14/2007CA2630030A1 Diagnostic methods for pain sensitivity and chronicity and for tetrahydrobiopterin-related disorders
06/14/2007CA2629822A1 Methods and compositions for inhibiting hiv infection
06/13/2007EP1795615A2 Method of classifying gene expression strength in lung cancer tissues
06/13/2007EP1795614A1 Diagnostic method and products useful therein
06/13/2007EP1795613A1 Biosensor with the use of pigment-synthesis gene of purple non-sulfur bacterium and method of constructing the biosensor
06/13/2007EP1795612A1 Nucleic acid analysis method
06/13/2007EP1795611A1 Selection marker system and method for screening a choline tolerant plant cell
06/13/2007EP1795610A1 A composition of nucleic acid sequences, specific for inflammatory disease, in particular rheumatoid arthritis
06/13/2007EP1795609A1 Method for the diagnosis and treatment of cardiovascular diseases
06/13/2007EP1795608A1 Use of a 4' -phosphopantetheinyl transferase as a target for identifying antibiotic molecules
06/13/2007EP1795607A1 Stabilized cholinesterase substrate solution
06/13/2007EP1795606A1 Method for screening for proteases and their substrates
06/13/2007EP1795605A1 Chromogenic test in the presence of cells
06/13/2007EP1795603A1 Process for synthesis of derivatives, compound library, method for making the mase, and screening method
06/13/2007EP1795597A2 Nucleic acids isolated in neuroblastoma
06/13/2007EP1795595A1 Gene specifically expressed in postmitotic dopaminergic neuron precursor cells
06/13/2007EP1795594A2 Method of evaluating the function of phagocyte and utilization thereof
06/13/2007EP1795593A1 Target nucleic acid of retrovirus integration
06/13/2007EP1795590A1 Mixed cell diagnostic systems
06/13/2007EP1795205A2 Method for accessing microbial diversity
06/13/2007EP1795203A2 Fhit proteins and nucleic acids and methods based thereon
06/13/2007EP1794590A2 Enhanced stability of proteins immobilized on nanoparticles
06/13/2007EP1794329A2 Porcine reproductive and respiratory syndrome isolates and methods of use
06/13/2007EP1794328A2 Assay for detecting and quantifying hiv-1
06/13/2007EP1794326A2 Use of photopolymerization for amplification and detection of a molecular recognition event
06/13/2007EP1794325A2 Methods for the detection of ovarian cancer
06/13/2007EP1794321A2 Markers of alterations in the y chromosome and uses therefor
06/13/2007EP1794320A1 Method for generating transcripts
06/13/2007EP1794319A2 Method for providing dna fragments derived from an archived sample
06/13/2007EP1794318A2 Drug screening and molecular diagnostic test for early detection of colorectal cancer: reagents, methods and kits thereof
06/13/2007EP1794317A2 Assessment of ctla-4 polymorphisms in ctla-4 blockade therapy
06/13/2007EP1794315A2 Methods for the utilization of novel target genes related to immune-mediated diseases
06/13/2007EP1794314A2 Diagnostics and therapeutics for diseases associated with vasoactive intestinal peptide receptor 1 (vpac1)
06/13/2007EP1794313A2 Screening methods using c-abl, fyn and syk in combination with tau protein
06/13/2007EP1794311A2 Genetic selection of small molecule modulators of protein-protein interactions
06/13/2007EP1794308A2 Corn event das-59122-7 and methods for detection thereof
06/13/2007EP1794181A2 Methods and materials for optimization of electronic transportation and hybridization reactions
06/13/2007EP1794173A1 Amplification blocker comprising intercalating nucleic acids (tna) containing intercalating pseudonucleotides (ipn)
06/13/2007EP1793864A2 Method of treating an inflammatory disease by double stranded ribonucleic acid
06/13/2007EP1793674A2 Sequence-specific inhibtion of small rna function
06/13/2007EP1697537B1 Microorganism detector
06/13/2007EP1558931B1 Analysis of pharmaceutical solubility and stability
06/13/2007EP1552003A4 Methods to assess quality of microarrays
06/13/2007EP1537231B1 Amp-activated protein kinase (ampk) inhibitor screening assay
06/13/2007EP1504085A4 Conductive microplate
06/13/2007EP1497453B1 Methods for measuring protein kinase and phosphatase activity